The Hindu Business Line : D.S. Brar `closely involved' in GVK group company

AFTER spending close to 27 years with Ranbaxy Laboratories Ltd, Mr Davinder S. Brar has decided to lend his expertise to GVK bioSciences, part of the Hyderabad-based GVK group.

Speaking to Business Line, Mr Brar said: "I am closely involved with GVK and also hold a substantial stake in the company."

He was, however, not willing to divulge the equity he holds or the investment made to acquire the stake.

The company is a contract research organisation that offers a range of integrated services in the areas of bio-informatics, medicinal chemistry, diagnostics and bioequivalence studies to biotech and pharmaceutical companies.

While the company is based in Boston, US, its research facilities are located in Hyderabad. Though in its infancy, the company is believed to have done a business of Rs 30-35 crore last year.

Besides this venture, Mr Brar is actively involved in Mphasis-BFL where he is a Director on the board.

"Along with McKinsey, I am involved in chalking out the long-term strategy for the company," he said. He also that he was no longer involved with Ranbaxy.

Mr Brar, along with the late Parvinder Singh, worked towards expanding Ranbaxy's operations in India and the US markets.

He was also responsible for taking the company towards the $1-billion mark and had framed Vision Garuda. However, last year Mr Brar decided to step down from the helm of affairs, with Dr Brian Tempest taking over the reins.

More Stories on : People | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page